Merck | MRK - Cash And Equivalent



Merck reported EUR1.17B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Adidas EUR 767M 665M Jun/2025
Adyen EUR 9.97B 1.23B Dec/2024
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.41B 4M Jun/2025
Amadeus IT EUR 1.49B 444.3M Mar/2025
Amarin USD 119.52M 1.51M Mar/2025
AstraZeneca USD 7.06B 1.83B Jun/2025
BASF EUR 2.52B 203M Jun/2025
Bayer EUR 4.56B 542M Jun/2025
Beiersdorf EUR 1.17B 40M Jun/2025
Covestro EUR 489M 253M Jun/2025
Danone EUR 1.62B 144M Jun/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.72B 644.08M Jun/2025
Galapagos EUR 108.07M 43.83M Mar/2025
Genmab DKK 1.3B 323M Jun/2025
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.6B 865M Jun/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Henkel EUR 2.87B 18M Jun/2025
Hikma Pharmaceutical USD 188M 188M Dec/2024
Infineon EUR 1.28B 64M Jun/2025
Linde USD 4.79B 64M Jun/2025
Lonza CHF 1.11B 286M Dec/2024
Merck EUR 1.17B 161M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Philips EUR 1.82B 629M Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Sanofi 15.36B 7.37B Jun/2025
UCB EUR 1.57B 1.14B Dec/2024